![Special public comment period begins March 27 for guidance document](https://unos.org/wp-content/uploads/News_Patient-safety-1-line-e1560353275245.png)
Special public comment period begins March 27 for guidance document
Document addresses communication with patients regarding increased risk donors; recording of an April 4 webinar is now available.
Document addresses communication with patients regarding increased risk donors; recording of an April 4 webinar is now available.
Review the FDA’s most recent update published on March 9, 2017.
The Centers for Disease Control and Prevention (CDC) has issued an additional Epi-X update regarding reports of potentially contaminated organ preservation solution. This is an update to information posted on January 12.
Read the updated FDA alert that contains specific recommendations for health care facilities and staff.
Some of the adverse events reported have been related to cardiothoracic surgery, although other reports did not specify the procedure.
On August 10 we implemented policy changes related to screening donor organs for infectious diseases. As a result, if your candidate was listed as willing to accept a Hepatitis B Core antibody positive organ, then the system also indicated YES for willingness to accept an HBV NAT positive organ.